SE8402199D0 - Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten - Google Patents

Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten

Info

Publication number
SE8402199D0
SE8402199D0 SE8402199A SE8402199A SE8402199D0 SE 8402199 D0 SE8402199 D0 SE 8402199D0 SE 8402199 A SE8402199 A SE 8402199A SE 8402199 A SE8402199 A SE 8402199A SE 8402199 D0 SE8402199 D0 SE 8402199D0
Authority
SE
Sweden
Prior art keywords
dergocrine
pharmaceutical preparation
preparation containing
calcium antagonists
pharmaceutically acceptable
Prior art date
Application number
SE8402199A
Other languages
English (en)
Other versions
SE8402199L (sv
SE465751B (sv
Inventor
D Welzel
H Buhlmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8402199D0 publication Critical patent/SE8402199D0/sv
Publication of SE8402199L publication Critical patent/SE8402199L/sv
Publication of SE465751B publication Critical patent/SE465751B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
SE8402199A 1983-04-22 1984-04-19 Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist SE465751B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3314607 1983-04-22

Publications (3)

Publication Number Publication Date
SE8402199D0 true SE8402199D0 (sv) 1984-04-19
SE8402199L SE8402199L (sv) 1984-10-23
SE465751B SE465751B (sv) 1991-10-28

Family

ID=6197070

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8402199A SE465751B (sv) 1983-04-22 1984-04-19 Farmaceutiskt preparat innehaallande co-dergocrin och en kalciumantagonist

Country Status (27)

Country Link
US (2) US4617306A (sv)
JP (1) JPS59205318A (sv)
AT (1) AT393625B (sv)
AU (1) AU571218B2 (sv)
BE (1) BE899434A (sv)
CA (1) CA1218932A (sv)
CH (1) CH658992A5 (sv)
CY (1) CY1499A (sv)
DD (1) DD217712A5 (sv)
DK (1) DK165965C (sv)
FR (1) FR2544614B1 (sv)
GB (1) GB2138678B (sv)
GR (1) GR81973B (sv)
HK (1) HK100289A (sv)
HU (1) HU192050B (sv)
IE (1) IE57468B1 (sv)
IL (1) IL71601A (sv)
IT (1) IT1199114B (sv)
LU (1) LU85331A1 (sv)
MY (1) MY100397A (sv)
NL (1) NL188891C (sv)
NZ (1) NZ207917A (sv)
PH (1) PH20922A (sv)
PT (1) PT78455B (sv)
SE (1) SE465751B (sv)
SG (1) SG53889G (sv)
ZA (1) ZA842993B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159604B1 (en) * 1984-04-09 1990-11-07 Toyo Boseki Kabushiki Kaisha Sustained-release preparation applicable to mucous membrane in oral cavity
EP1970052A2 (en) * 1999-02-09 2008-09-17 Pfizer Products Inc. Basic drug compositions with enhanced bioavailability
US6209563B1 (en) 2000-01-07 2001-04-03 Saturn Electronics & Engineering, Inc. Solenoid control valve
US6321767B1 (en) 2000-01-10 2001-11-27 Saturn Electronics & Engineering, Inc. High flow solenoid control valve
US6581634B2 (en) 2000-01-10 2003-06-24 Saturn Electronics & Engineering, Inc. Solenoid control valve with particle gettering magnet
US20090166274A1 (en) * 2007-05-24 2009-07-02 Eaton Corporation Engine valve with a combined engine oil filter and valve actuator solenoid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5468M (sv) * 1966-06-24 1967-10-16
SE351565B (sv) * 1967-08-17 1972-12-04 Sandoz Ag
SE426782B (sv) * 1975-05-31 1983-02-14 Sandoz Ag Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter
JPS5487177A (en) * 1977-12-23 1979-07-11 Fujitsu Ltd Component positioning unit
WO1980001242A1 (en) * 1978-12-21 1980-06-26 Sandoz Ag Galenical preparation
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
GB2063670A (en) * 1979-11-28 1981-06-10 Sandoz Products Ltd Ergots and their use in treating minimal brain dysfunction

Also Published As

Publication number Publication date
CY1499A (en) 1990-08-03
GB2138678A (en) 1984-10-31
HU192050B (en) 1987-05-28
GR81973B (sv) 1984-12-12
NL8401155A (nl) 1984-11-16
FR2544614B1 (fr) 1987-08-21
IE840977L (en) 1984-10-22
HK100289A (en) 1989-12-29
FR2544614A1 (fr) 1984-10-26
DD217712A5 (de) 1985-01-23
ATA133784A (de) 1991-05-15
ZA842993B (en) 1985-11-27
AT393625B (de) 1991-11-25
SE8402199L (sv) 1984-10-23
HUT37889A (en) 1986-03-28
DK165965C (da) 1993-07-26
DK201884D0 (da) 1984-04-18
PT78455B (en) 1986-05-27
DK165965B (da) 1993-02-22
SE465751B (sv) 1991-10-28
GB2138678B (en) 1986-11-05
CH658992A5 (de) 1986-12-31
IE57468B1 (en) 1993-01-27
MY100397A (en) 1990-09-17
BE899434A (fr) 1984-10-16
NL188891C (nl) 1992-11-02
JPS59205318A (ja) 1984-11-20
IT1199114B (it) 1988-12-30
US4617306A (en) 1986-10-14
LU85331A1 (fr) 1984-11-28
AU2712084A (en) 1984-10-25
NZ207917A (en) 1988-05-30
JPH0564124B2 (sv) 1993-09-14
US4797404A (en) 1989-01-10
IL71601A0 (en) 1984-07-31
CA1218932A (en) 1987-03-10
PH20922A (en) 1987-06-05
GB8410363D0 (en) 1984-05-31
SG53889G (en) 1989-12-08
IT8448082A0 (it) 1984-04-20
AU571218B2 (en) 1988-04-14
IL71601A (en) 1988-12-30
PT78455A (en) 1984-05-01
DK201884A (da) 1984-10-23

Similar Documents

Publication Publication Date Title
NO330934B1 (no) Flytende farmasoytisk preparat samt anvendelse og fremstilling derav.
RU94013439A (ru) Гетероциклические соединения, способ их получения, фармацевтическая композиция и способ лечения
NO971889L (no) Forbindelser og sammensetninger for levering av aktive midler
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
BR9907995A (pt) Métodos imunológicos para modular miostatina em sujeitos vertebrados
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
NO960630D0 (no) Heterocykler anvendelige som neurokinin antagonister
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
ES8506615A1 (es) Un procedimiento para la preparacion de carboxamidas
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DK0556322T3 (da) Aminosulfonylurinstof-ACAT-inhibitorer
SE9402880D0 (sv) New peptide derivatives
SE8402199D0 (sv) Pharmazeutisches preparat enthaltend co-dergocrine und einen calcium-antagonisten
DK0758312T3 (da) Substituerede fusionerede og broforbundne bicykliske forbindelser som terapeutiske midler
EA200100098A1 (ru) Соли пароксетина
SE8403659D0 (sv) Synergistic pharmaceutical composition
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
DE3380923D1 (de) Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
HUP0000812A2 (hu) Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
SE8303886L (sv) Synergetisk antihypertensiv farmaceutisk komposition
DK239084A (da) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3-carbonitriler
GB9211277D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8402199-7

Effective date: 19941110

Format of ref document f/p: F